These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38729666)

  • 1. Diagnosing and Managing Urinary Tract Infections in Kidney Transplant Recipients.
    McAteer J; Tamma PD
    Infect Dis Clin North Am; 2024 Jun; 38(2):361-380. PubMed ID: 38729666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unitary Tract Infection Treatment: When to Use What Agents including Beta-lactam Combination Agents.
    Yassin A; Kaye KS; Bhowmick T
    Infect Dis Clin North Am; 2024 Jun; 38(2):295-310. PubMed ID: 38594140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
    Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM;
    Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.
    Alevizakos M; Nasioudis D; Mylonakis E
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
    Pinheiro HS; Mituiassu AM; Carminatti M; Braga AM; Bastos MG
    Transplant Proc; 2010 Mar; 42(2):486-7. PubMed ID: 20304172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.
    Vidal E; Torre-Cisneros J; Blanes M; Montejo M; Cervera C; Aguado JM; Len O; Carratalá J; Cordero E; Bou G; Muñoz P; Ramos A; Gurguí M; Borrell N; Fortún J;
    Transpl Infect Dis; 2012 Dec; 14(6):595-603. PubMed ID: 22650416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome.
    Brakemeier S; Taxeidi SI; Zukunft B; Schmidt D; Gaedeke J; Dürr M; Hansen S; Budde K
    Transplant Proc; 2017 Oct; 49(8):1757-1765. PubMed ID: 28923621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing
    Gutiérrez-Gutiérrez B; Pérez-Nadales E; Pérez-Galera S; Fernández-Ruiz M; Carratalà J; Oriol I; Cordero E; Lepe JA; Tan BH; Corbella L; Paul M; Natera AM; David MD; Montejo M; Iyer RN; Pierrotti LC; Merino E; Steinke SM; Rana MM; Muñoz P; Mularoni A; van Delden C; Grossi PA; Seminari EM; Gunseren F; Lease ED; Roilides E; Fortún J; Arslan H; Coussement J; Tufan ZK; Pilmis B; Rizzi M; Loeches B; Eriksson BM; Abdala E; Soldani F; Lowman W; Clemente WT; Bodro M; Fariñas MC; Kazak E; Martínez-Martínez L; Aguado JM; Torre-Cisneros J; Pascual Á; Rodríguez-Baño J;
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0110221. PubMed ID: 34370578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of urinary tract infections and development of urinary-specific antibiogram for kidney transplant recipients.
    Korayem GB; Zangeneh TT; Matthias KR
    J Glob Antimicrob Resist; 2018 Mar; 12():119-123. PubMed ID: 28859935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Goldman JD; Julian K
    Clin Transplant; 2019 Sep; 33(9):e13507. PubMed ID: 30793386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
    Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ;
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales.
    Barnawi MH; Thabit AK; Almasri DM; Bulbol S
    Eur J Clin Pharmacol; 2023 Mar; 79(3):399-405. PubMed ID: 36629890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function.
    Ramadas P; Rajendran PP; Krishnan P; Alex A; Siskind E; Kadiyala A; Jayaschandran V; Basu A; Bhaskaran M; Molmenti EP
    PLoS One; 2014; 9(3):e91289. PubMed ID: 24637786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients.
    Coussement J; Kaminski H; Scemla A; Manuel O
    Curr Opin Infect Dis; 2020 Dec; 33(6):419-425. PubMed ID: 33148983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
    Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
    Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A middle east systematic review and meta-analysis of bacterial urinary tract infection among renal transplant recipients; Causative microorganisms.
    Behzad D; Hakimeh A; Hossein R; Khaledi A
    Microb Pathog; 2020 Nov; 148():104458. PubMed ID: 32835776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.